Your Partner. For science. For life.
Battling chronic ailments. Evolving science. Improving quality of life. Even helping people get a better night’s sleep. Our portfolio companies are positively impacting the world every day with their visionary people and life-changing products.
What they do.
Triangle Research Labs provides fresh and cyropreserved hepatocytes, or liver cells, and other products for academic, pharmaceutical and CRO research.
PBM Capital founded TRL and oversaw operations until 2016 when it sold the business to Lonza (SIX:LONN).
Achievement of Note:
TRL is widely recognized as world’s fastest growing hepatocyte provider.
How they‘re improving the quality of peoples lives:
TRL provides products and services that allow pharmaceutical companies to make drugs better and safer for patients, supplying the hepatocytes that are used for testing drug-drug interactions, toxicity and a number of other drug characteristics.